|
Mar 8
|
Does Inovio (INO) Have the Potential to Rally 122.92% as Wall Street Analysts Expect?
|
|
Mar 7
|
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Q4 2023 Earnings Call Transcript
|
|
Mar 7
|
Q4 2023 Inovio Pharmaceuticals Inc Earnings Call
|
|
Mar 7
|
Inovio Pharmaceuticals (INO) Q4 2023 Earnings Call Transcript
|
|
Mar 6
|
INOVIO Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights
|
|
Mar 6
|
Geneos Therapeutics to Present New Clinical Data on GNOS-PV02 at the 2024 American Association for Cancer Research (AACR) Annual Meeting
|
|
Feb 2
|
INOVIO Reports Inducement Grant Under Inducement Plan
|
|
Jan 30
|
How Much Upside is Left in Inovio (INO)? Wall Street Analysts Think 223.72%
|
|
Jan 12
|
Inovio Pharma (INO) Stock Rallies 134% in a Month: Here's Why
|
|
Jan 4
|
INOVIO and Coherus Announce Clinical Collaboration to Advance Development of INO-3112 in Combination with LOQTORZI⢠(toripalimab-tpzi)
|
|
Nov 10
|
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Q3 2023 Earnings Call Transcript
|
|
Nov 10
|
Inovio Pharmaceuticals (INO) Q3 2023 Earnings Call Transcript
|
|
Nov 9
|
INOVIO Reports Third Quarter 2023 Financial Results and Operational Highlights
|
|
Aug 10
|
Inovio Pharmaceuticals (INO) Q2 2023 Earnings Call Transcript
|
|
Aug 9
|
Inovio Pharmaceuticals (INO) Reports Q2 Loss, Tops Revenue Estimates
|
|
Aug 9
|
INOVIO Announces Second Quarter 2023 Financial Results and Provides Strategic Update
|